These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19299272)

  • 1. A comparison of low-molecular-weight heparin and combined therapy of low-molecular-weight heparin with an anti-inflammatory agent in the treatment of superficial vein thrombosis.
    Uncu H
    Phlebology; 2009 Apr; 24(2):56-60. PubMed ID: 19299272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
    Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
    Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis.
    Superficial Thrombophlebitis Treated By Enoxaparin Study Group
    Arch Intern Med; 2003 Jul; 163(14):1657-63. PubMed ID: 12885680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical management of acute superficial vein thrombosis of the saphenous vein.
    Scovell SD; Ergul EA; Conrad MF
    J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):109-117. PubMed ID: 29097174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal heparin spray: a new formula in adjunctive treatment of superficial venous thrombosis.
    Górski G; Szopiński P; Michalak J; Marianowska A; Borkowski M; Geremek M; Trochimczuk M; Brotánek J; Sárník S; Seménka J; Wilkowski D; Noszczyk W
    Angiology; 2005; 56(1):9-17. PubMed ID: 15678251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial.
    Righini M; Robert-Ebadi H; Glauser F; Blondon M; Ouvry P; Diamand JM; Tissot A; Frappe P; Quere I; Kahn SR; Galanaud JP; Le Gal G
    J Thromb Haemost; 2019 Mar; 17(3):507-510. PubMed ID: 30656824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of compression stockings versus no compression on isolated superficial vein thrombosis of the legs: a randomized clinical trial.
    Boehler K; Kittler H; Stolkovich S; Tzaneva S
    Eur J Vasc Endovasc Surg; 2014 Oct; 48(4):465-71. PubMed ID: 25116277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution in the pharmacological treatment of venous thrombosis according to evidence-based medicine].
    Manganaro A; Giannino D; Lembo D; Bruni F; Consolo F
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):41-51. PubMed ID: 11253339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total knee replacement: prevention of deep-vein thrombosis using pharmacological (low-molecular-weight heparin) and mechanical (intermittent foot sole pump system) combined prophylaxis. Preliminary results.
    Giannoni MF; Ciatti R; Capoccia L; Ruggiero M; Dauri M; Mariani PP
    Int Angiol; 2006 Sep; 25(3):316-21. PubMed ID: 16878083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic management of superficial venous thrombosis with calcium nadroparin. Dosage testing and comparison with a non-steroidal anti-inflammatory agent].
    Titon JP; Auger D; Grange P; Hecquet JP; Remond A; Ulliac P; Vaissié JJ
    Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):160-6. PubMed ID: 8024227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism.
    Grau E; Tenias JM; Real E; Medrano J; Ferrer R; Pastor E; Selfa S
    Am J Hematol; 2001 May; 67(1):10-4. PubMed ID: 11279651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course and the recanalization rate of superficial vein thrombosis treated with low-molecular-weight heparin.
    Spirkoska A; Jezovnik MK; Poredos P
    Angiology; 2015 Apr; 66(4):381-6. PubMed ID: 24807875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis.
    Quenet S; Laporte S; Décousus H; Leizorovicz A; Epinat M; Mismetti P;
    J Vasc Surg; 2003 Nov; 38(5):944-9. PubMed ID: 14603198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial.
    Prandoni P; Tormene D; Pesavento R;
    J Thromb Haemost; 2005 Jun; 3(6):1152-7. PubMed ID: 15946202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support.
    Qian Y; Xie H; Tian R; Yu K; Wang R
    COPD; 2014 Apr; 11(2):171-6. PubMed ID: 24087989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of lower extremity superficial vein thrombosis with low molecular weight heparin.
    Dzupina A; Wald M; Lee BB; Stvrtinova V
    Bratisl Lek Listy; 2016; 117(10):595-600. PubMed ID: 27826975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
    Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the low-molecular-weight heparin nadroparin during pregnancy. A review.
    Makatsaria AD; Bitsadze VO; Dolgushina NV
    Curr Med Res Opin; 2003; 19(1):4-12. PubMed ID: 12661774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of unfractionated heparin vs low molecular weight heparin in the treatment of acute deep vein thrombosis.
    Naz R; Naz S; Mehboob M; Khalid GH
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):601-4. PubMed ID: 19810295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.